| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.3M | -36.6% |
| R&D Expense | $4.5M | -48.2% |
| SG&A Expense | $17.7M | -28.4% |
| Operating Income | -$20.5M | +36.3% |
| Income Tax | $2K | +0.0% |
| Net Income | -$17.4M | +44.4% |
| EPS (Basic) | -$26.92 | +33.3% |
| EPS (Diluted) | -$26.92 | +33.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $371K | -75.8% |
| Accounts Receivable | $2.1M | +24.5% |
| Inventory | $4.6M | -22.0% |
| Current Assets | $9.3M | -28.9% |
| Total Assets | $16.8M | -19.8% |
| Current Liabilities | $11.4M | +36.5% |
| Long-term Debt | $5.5M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | +26.0% |
| Capital Expenditures | $45K | -75.9% |
| Investing Cash Flow | -$45K | -104.0% |
| Financing Cash Flow | $14.5M | +146.7% |
| Free Cash Flow | -$15.8M | +26.4% |
| Total Liabilities |
| $18.1M |
| +29.6% |
| Stockholders' Equity | -$1.3M | -116.9% |